VisionTech Medical-B (02251) announced that it repurchased 34,300 shares at a total cost of HK$296,000 on September 9, 2026. This buyback reflects the company's ongoing commitment to enhancing shareholder value through strategic capital management. The repurchased shares are part of the firm's broader initiatives to optimize its capital structure in a dynamic market environment.

The transaction underscores the company's confidence in its long-term growth prospects, as it continues to navigate the evolving healthcare technology landscape. Management's proactive approach to share repurchases signals a disciplined allocation of resources, aimed at delivering sustainable returns to investors.

This action aligns with the company's previously stated buyback program, demonstrating consistent execution of its capital return policy. Market participants often view such moves as a positive indicator of financial health and management's belief in the intrinsic value of the business. As of now, no further details have been disclosed regarding additional repurchase plans beyond this specific transaction.